Last reviewed · How we verify
Аrgon-oxygen breathing mixture — Competitive Intelligence Brief
phase 3
Medical gas mixture
Critical Care / Resuscitation
Small molecule
Live · refreshed every 30 min
Target snapshot
Аrgon-oxygen breathing mixture (Аrgon-oxygen breathing mixture) — Negovsky Reanimatology Research Institute. An argon-oxygen breathing mixture enhances tissue oxygenation and reduces hypoxia by delivering a gas combination with optimized oxygen availability and inert gas properties.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Аrgon-oxygen breathing mixture TARGET | Аrgon-oxygen breathing mixture | Negovsky Reanimatology Research Institute | phase 3 | Medical gas mixture |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Medical gas mixture class)
- Negovsky Reanimatology Research Institute · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Аrgon-oxygen breathing mixture CI watch — RSS
- Аrgon-oxygen breathing mixture CI watch — Atom
- Аrgon-oxygen breathing mixture CI watch — JSON
- Аrgon-oxygen breathing mixture alone — RSS
- Whole Medical gas mixture class — RSS
Cite this brief
Drug Landscape (2026). Аrgon-oxygen breathing mixture — Competitive Intelligence Brief. https://druglandscape.com/ci/rgon-oxygen-breathing-mixture. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab